Published on 24/11/2025

Governance Structures and SteerCo Models to Support Dashboards, Status Reporting & RAID Logs

Effective governance structures and Steering Committee (SteerCo) models are pivotal to the success of clinical trials. They facilitate clear communication, decision-making, and responsibility assignments, especially when managing dashboards, status reporting, and RAID (Risks, Assumptions, Issues, and Dependencies) logs. In this guide, we will explore how to set up robust governance frameworks tailored for effective clinical project management, aligning with regulatory compliance in the US, UK, and EU contexts.

Understanding Governance Structures in Clinical Trials

Governance structures within clinical trials define the framework for oversight, decision-making, and stakeholder involvement. These structures ensure that trials are conducted in compliance with ethical principles and regulatory standards, ultimately enhancing the credibility of data collected.

1. The Importance of Governance in Clinical Trials

The governance framework serves several critical functions in clinical trial management:

• Oversight: Ensures all activities comply with ICH-GCP, FDA, EMA, and other relevant regulations.
• Accountability: Defines roles and responsibilities, holding individuals or groups accountable for specific aspects of the trial.
• Communication: Establishes clear channels of communication among stakeholders to facilitate decision-making and problem solving.
• Risk Management: Implements processes for identifying and mitigating risks associated with trial management.

The establishment of an effective governance model minimizes the risks of protocol deviations and enhances the integrity of clinical data, which is paramount for regulatory submissions.

2. Key Components of Governance Structures

A well-defined governance structure in clinical trials typically comprises the following key components:

• Steering Committee (SteerCo): A group of senior stakeholders responsible for overseeing the trial’s progress and resolving high-level issues.
• Project Management Office (PMO): Supports day-to-day management of the trial, ensuring adherence to timelines and budgets.
• Clinical Study Team: Comprised of medical and operational staff who execute the trial protocols and manage patient interactions.
• Regulatory Affairs Team: Ensures compliance with all regulatory requirements at local, national, and international levels.
• Data Management Team: Handles data integrity, quality control, and analysis requirements throughout the study lifecycle.

Setting Up a Steering Committee (SteerCo) Model

A Steering Committee (SteerCo) acts as a governing body for the trial, guiding strategic decisions. Here we outline the crucial steps for establishing a successful SteerCo model:

1. Define the Purpose and Scope

Clearly articulate the objectives of the SteerCo. This may include:

• Providing direction for the clinical study.
• Resolving conflicts that may arise.
• Reviewing progress reports and addressing concerns.
• Making strategic decisions pertaining to trial operations, including adaptations to study design as necessary.

2. Identify Committee Members

The selection of members for the SteerCo is critical. Ideal candidates might include:

• Senior leadership from the sponsor organization.
• Representatives from key functional areas, such as clinical operations, regulatory affairs, and data management.
• External advisors with expertise relevant to the study focus, such as the therapeutic area of the trial, like ovarian cancer clinical trials.

3. Outline Roles and Responsibilities

Clearly define the roles and responsibilities of each SteerCo member to avoid overlap and ensure accountability:

• Chairperson: Leads meetings and sets agendas.
• Members: Contribute insights, make recommendations, and participate in decision-making processes.
• Secretariat: Prepares meeting materials, records minutes, and manages follow-ups.

4. Establish Meeting Protocols

Regular meetings are vital for remaining aligned on trial progress. Protocols should include:

• Frequency of meetings (e.g., monthly, quarterly).
• Duration of meetings (commonly 1-2 hours).
• Format (e.g., virtual, in-person).

Integrating Dashboards for Status Reporting

Dashboards play an instrumental role in clinical study management by providing visual representations of key performance indicators (KPIs). They facilitate quick assessments of trial progress, allowing stakeholders to make informed decisions. Here is a structured approach to designing effective dashboards for clinical trials.

1. Identify Key Metrics

Select critical metrics that reflect the success of clinical trials. Common metrics to include in a dashboard are:

• Enrollment rates: Track patient recruitment against goals.
• Site performance: Monitor each involved site’s contribution to enrollment and data collection.
• Data quality indicators: Measure the completeness and accuracy of data collected during the trial.
• Safety reporting: Alert on adverse events and serious adverse events.

2. Choose an Effective Dashboard Tool

Select a reporting tool or platform that suits the needs of your clinical study. Consider factors such as:

• User interface: Must be intuitive for all stakeholders.
• Integration capabilities: Ensure compatibility with existing data systems.
• Real-time reporting: Dashboards should provide up-to-date information without delays.

3. Design the Dashboard Layout

Design the dashboard layout focusing on usability:

• Clear navigation: Allow users to easily access different sections of the dashboard.
• Visuals: Leverage graphs, charts, and color codes to highlight key information and trends.
• User-defined views: Enable stakeholders to customize dashboard elements according to their needs.

4. Train Stakeholders

Provide adequate training for users to ensure effective utilization of the dashboard:

• Conduct training sessions focusing on the features and functionalities of the dashboard.
• Develop user manuals or video tutorials for ongoing reference.

Maintaining RAID Logs for Effective Risk Management

RAID logs are an essential tool for tracking risks, assumptions, issues, and dependencies that may impact the successful execution of clinical trials. Following are the structured steps to maintain effective RAID logs:

1. Identify and Document Risks

Conduct risk assessments regularly to identify and document potential risks associated with the trial. This can include:

• Operational risks, such as delays in patient recruitment.
• Regulatory risks associated with compliance failures.
• Financial risks linked to budget overruns.

2. Monitor Assumptions

Document key assumptions that underpin the success of the trial. Assumptions can influence risk levels, particularly when they evolve:

• Assumptions about patient demographics.
• Funding availability assumptions.
• Availability of resources assumed at the beginning of planning.

3. Track Issues and Dependencies

Set up mechanisms to track issues as they arise and document dependencies that may affect project milestones:

• Use issue tracking methods such as prioritizing by severity and impact.
• Maintain a list of dependencies between tasks to avoid bottlenecks.

4. Review and Update the RAID Log Regularly

RAID logs should be living documents that are reviewed and updated frequently:

• Schedule regular reviews with the SteerCo to assess the status of identified risks and issues.
• Assign responsibility for action items and ensure follow-ups are documented.

Conclusion

The establishment of a robust governance structure and effective SteerCo models are vital components in managing clinical trials successfully. By implementing dashboards, status reporting, and RAID logs, clinical research professionals can maintain oversight, evaluate trial progress, and ensure adherence to regulatory standards. This systematic approach to clinical project management ultimately leads to improved outcomes in good labs clinical trials and other complex studies, such as nucleus clinical trials and eisf clinical trials. Well-executed governance models are fundamental to addressing the growing complexities in the clinical research landscape and will drive higher levels of success in delivering reliable trial results.